Mercer Global Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
Mercer Global Advisors's AMRX Position: Q3 2026 in Review
Mercer Global Advisors reduced its Amneal Pharmaceuticals (AMRX) stake by 0.19% in Q3 2026, selling an estimated $1.44K and leaving 42,831 shares worth $863K. The position accounts for ﹤0.01% of the portfolio, ranked #1941.
Mercer Global Advisors first reported a position in AMRX in Q3 2025 and has held it in 5 quarters since. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- Mercer Global Advisors held 42,831 shares of Amneal Pharmaceuticals worth $863K as of Q3 2026.
- Mercer Global Advisors sold 80 Amneal Pharmaceuticals shares in Q3 2026, an estimated $1.44K.
- Amneal Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q3 2026, its #1941 holding.
- Mercer Global Advisors first reported a position in Amneal Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on Mercer Global Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.